ID   CBC3T-1
AC   CVCL_C1YT
DR   CCRID; 4201PAT-CCTCC02152
DR   Wikidata; Q123030857
RX   Patent=CN115786262A;
RX   PubMed=37966669;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2022169.
CC   Population: Chinese.
CC   Doubling time: 52 hours (Patent=CN115786262A; PubMed=37966669).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=37966669).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): Patent=CN115786262A; PubMed=37966669
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 22
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 13,22
ST   D19S433: 13,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 19,25
ST   D2S441: 12
ST   D3S1358: 16
ST   D5S818: 9,10
ST   D6S1043: 11
ST   D7S820: 12
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   Patent=CN115786262A;
RA   Meng W.-B., Bai M.-Z., Jiang N.-Z., Tian L.;
RT   "A human hilar cholangiocarcinoma cell line CBC3T-1 and application
RT   thereof.";
RL   Patent number CN115786262A, 14-Mar-2023.
//
RX   PubMed=37966669; DOI=10.1007/s13577-023-01003-4; PMCID=PMC10764469;
RA   Bai M.-Z., Jiang N.-Z., Fu W.-K., Huang C.-F., Tian L., Mi N.-N.,
RA   Gao L., Ma H.-D., Lu Y.-W., Cao J., Zhang C., Yue P., Zhang Y.,
RA   Lin Y.-Y., Meng W.-B., Li X.;
RT   "Establishment and characterization of a novel hilar
RT   cholangiocarcinoma cell line, CBC3T-1.";
RL   Hum. Cell 37:364-375(2024).
//